Salfopride SR Tablets 300 mg (Salfopride Hydrochloride)

Adult dose

Administer 300 mg of Salfopride Hydrochloride sustained-release tablet orally once a day after meals. This medication should be taken whole without chewing or crushing.

This medication should not be used in patients who have bleeding. This is because the risk of bleeding may worsen in patients with bleeding risks such as hemophilia or gastrointestinal ulcer. It is advisable not to administer this medication to pregnant women or women who may become pregnant, as adverse effects on the fetus have been reported in animal experiments. It should be used with caution in menstruating women or patients with a tendency to bleed, as this medication may increase bleeding. Patients taking anticoagulants or platelet aggregation inhibitors should also be careful as the risk of bleeding may increase. Special caution is required when administering this medication to patients with severely impaired renal function or the elderly, as it may affect drug excretion. During the use of this medication, various adverse reactions such as hives, dyspepsia, headache, cough, and changes in blood pressure may occur, so symptoms should be closely monitored. If bleeding symptoms, blood abnormalities, or liver dysfunction occur, discontinue the medication immediately and consult healthcare personnel. Regular blood tests are advisable for those taking this medication long-term to detect adverse reactions early. Caution is necessary when administered in conjunction with anticoagulants or platelet inhibitors as this may increase the risk of bleeding. It is recommended that pregnant or nursing women do not use this medication, and if it is absolutely necessary, it is advisable to avoid breastfeeding. Safety in children has not been established, so its use in children is not recommended. This medication should be stored out of reach of children, and it is advisable to avoid transferring it to another container as this may compromise the quality of the medication.

Serious side effects

Hives, gastrointestinal bleeding (such as hematemesis and melena), cerebral hemorrhage, subcutaneous bleeding, agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver dysfunction, jaundice, fractures, gastric perforation, bowel obstruction, exacerbation of Crohn's disease, liver cirrhosis, exacerbation of diabetes, angina, exacerbation of coronary artery disease, myocardial infarction, peripheral vascular disease, cerebral infarction, atherosclerosis, intermittent claudication, stroke, laryngitis, bruising, worsening of renal dysfunction, gallbladder cancer, chest pain, peripheral edema, nasal polyps,

Mild side effects

• Dyspepsia
• constipation
• diarrhea
• gastritis
• gastrointestinal dysfunction
• hypoglycemia
• decreased appetite
• pain in the back
• muscle weakness
• headache

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store it at room temperature between 1°C and 30°C. Proper storage can help maintain the effectiveness of the medication over time.

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle